USciences' MBA Program Again Ranked Among Elite Programs

Published on April 13, 2018

University of the Sciences’ MBA in Pharmaceutical and Healthcare Business continues to be ranked among the top tier programs in North America offering the degree. The program was named a tier one program for the fifth year in a row by CEO Magazine. The program’s online study option, was also ranked in the top 40 online MBA programs worldwide.

The ranking is determined by a weighting of key performance indicators considered to be of interest and value to potential students.  The indicators include international diversity, class sizes, student work experience, faculty-to-student ratio, quality of faculty, professional development, price and international exposure.

The USciences MBA in pharmaceutical and healthcare business is one of the few specialized MBA programs in the country and caters to the busy lifestyles of students with on-campus evening courses and online study options. The program and graduate outcomes were featured in a previous edition of CEO Magazine.

Our curriculum covers the core business topics you would expect from a world class MBA program—along with an added component specific to pharmaceutical and healthcare business, such as marketing and sales, research and development, regulation of prescription drugs and health economics. 

According to a survey of our MBA graduates:

84% had a job within six months

93% make more than $50,000—and 39% make more than $125,000

87% had received at least one promotion, or had changed jobs for a higher one, since graduation

91% were in the healthcare and pharmaceutical industries

Categories: News, Mayes College of Healthcare Business and Policy, Department of Pharmaceutical and Healthcare Business, Pharmaceutical and Healthcare Business, Awards and Honors,